EP2397133
Retínal afleiður og notkunaraðferðir þeirra til meðhöndlunar á augnkvillum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
20.6.2005EP published:
26.7.2017EP application number:
11163947.2
EP translation filed:
18.10.2017Grant published:
15.12.2017EPO information:
European Patent Register
Max expiry date:
19.6.2025Expiry date:
19.6.2019
Title:
Retinal derivatives and methods for the use thereof for the treatment of visual disorders
Timeline
Today
20.6.2005EP application
26.7.2017EP Publication
18.10.2017Translation submitted
15.12.2017Registration published
19.6.2019Expires
Owner
Name:
University of WashingtonAddress:
Intellectual Property and Technology Transfer, 4311, 11th Avenue NE Suite 500, Campus Box 354990, 98105-4608, Seattle, WA, US
Inventor
Name:
Palczewski, KrzysztofAddress:
Bay Village, OH, US
Name:
Batten, MatthewAddress:
Decatur, GA, US
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
580889 PDate:
18.6.2004Country:
US
Classification
Categories:
A61K 31/22, A61K 31/225, C07C 403/12, C07C 403/14, C07C 403/10, C07C 403/20
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 14.5.2018
Expires: 19.6.2019
Payer: Árnason Faktor